$BIIB Recent Headlines 10 best, 10 worst S&P 5
Post# of 72711
Posted On: 02/10/2015 10:34:50 AM
$BIIB Recent Headlines
10 best, 10 worst S&P 500 stocks so far in 2015 12:01 p.m. Feb. 2, 2015 - Philip van Doorn
U.S. stocks routed in final hour, end month in the red 4:16 p.m. Jan. 30, 2015 - Sara Sjolin
Biogen, Intercept post double-digit gains 11:45 a.m. Jan. 30, 2015 - Russ Britt
Google, Amazon, Visa highlight gainers; Apple hits record 11:12 a.m. Jan. 30, 2015 - Sue Chang
Biogen Idec shares rally 7.1% 9:31 a.m. Jan. 30, 2015 - Sue Chang
Biogen's profit nearly doubles 5:37 p.m. Jan. 29, 2015 - MarketWatch.com
Updates, advisories and surprises 5:31 p.m. Jan. 29, 2015 - MarketWatch
Biogen shares jump after company reports earnings 4:30 p.m. Jan. 29, 2015 - Russ Britt
Bed Bath & Beyond shares sink as sales miss consensus 6:48 p.m. Jan. 8, 2015 - MarketWatch
Drug trials, upgrades boost health-care sector 11:57 a.m. Jan. 8, 2015 - Russ Britt
Biogen rises 6.2% after strong study results 7:56 a.m. Jan. 8, 2015 - MarketWatch
Biogen Idec shares up 5% in premarket trade 7:43 a.m. Jan. 8, 2015 - Ciara Linnane
Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Barbara Kollmeyer
Small caps rise within view of uncharted territory 10:26 a.m. Dec. 22, 2014 - Michael Ashbaugh
S&P 500 back for another crack at major support 10:14 a.m. Dec. 12, 2014 - Michael Ashbaugh
Biogen's Alzheimer's surprise 11:24 a.m. Dec. 9, 2014 - The Trading Deck
U.S. stocks post biggest gain in a month 5:06 p.m. Dec. 2, 2014 - Barbara Kollmeyer
Bob Evans earnings in spotlight after hours 3:41 p.m. Dec. 2, 2014 - Sue Chang
Biogen Alzheimer’s drug skips to Phase 3 testing 3:22 p.m. Dec. 2, 2014 - Russ Britt
CIO Network Members 11:01 p.m. Feb. 9, 2015 - The Wall Street Journal Interactive Edition
Will Sangamo (SGMO) Disappoint This Earnings Season? - Analyst Blog 1:10 p.m. Feb. 9, 2015 - Zacks.com
Healthcare stock screen of the month: Accelerating after-tax margins 12:21 p.m. Feb. 9, 2015 - Seeking Alpha
No Deceleration Here: 14 Stocks With Accelerating Profits 5:29 p.m. Feb. 6, 2015 - Investors Business Daily
PDL BioPharma: Beware The 8% Dividend 1:07 p.m. Feb. 6, 2015 - Seeking Alpha
Stock Market News for February 06, 2015 - Market News 10:10 a.m. Feb. 6, 2015 - Zacks.com
Sanofi Misses on Q4 Earnings, Maintains Diabetes Guidance - Analyst Blog 9:04 a.m. Feb. 6, 2015 - Zacks.com
Teva Beats on Q4 Earnings By a Penny, Maintains Outlook - Analyst Blog 9:01 a.m. Feb. 6, 2015 - Zacks.com
Gilead, Amgen Q4 Earnings And Weak Outlook Affect Biotech ETFs 7:17 a.m. Feb. 6, 2015 - Seeking Alpha
Gilead, Amgen Q4 Earnings & Weak Outlook Affect Biotech ETFs - ETF News And Commentary 2:01 a.m. Feb. 6, 2015 - Zacks.com
bluebird bio's Thalassemia Drug Gets Breakthrough Status - Analyst Blog 6:20 p.m. Feb. 5, 2015 - Zacks.com
Biogen Idec (BIIB) On Momo Momentum Watch Today 3:44 p.m. Feb. 5, 2015 - TheStreet.com
Perrigo Beats on Earnings, FY15 Guidance In Line - Analyst Blog 10:15 a.m. Feb. 5, 2015 - Zacks.com
Allergan Beats Earnings Yet Again on Strong Revenues - Analyst Blog 9:52 a.m. Feb. 5, 2015 - Zacks.com
10-K: BIOGEN IDEC INC. 4:41 p.m. Feb. 4, 2015 - Edgar Online - (EDG = 10Q, 10K)
3 Stocks Dragging In The Health Care Sector 12:13 p.m. Feb. 4, 2015 - TheStreet.com
Biotech Stock Roundup: Biogen Impresses with 4Q Results, Gilead & AbbVie HCV Drugs in Focus - Analyst Blog 11:47 a.m. Feb. 4, 2015 - Zacks.com
Merck (MRK) Beats on Q4 Earnings but Guidance Falls Short - Analyst Blog 11:21 a.m. Feb. 4, 2015 - Zacks.com
Jim Cramer: Don't Bail on Biotech or Chipotle Mexican Grill 10:58 a.m. Feb. 4, 2015 - TheStreet.com
Today's Market: Stocks On The Rise, Blowout Earnings And Dividend Increases 10:44 a.m. Feb. 4, 2015 - Seeking Alpha
Valuable Updates on Pharmaceutical Companies: New Research on Avalanche Biotechnologies, BioCryst, Biogen, Biota Pharmaceuticals, and Bio-Techne 8:30 a.m. Today - PR Newswire - PRF
Isis Pharmaceuticals Earns $5 Million Milestone Payment From Biogen Idec 7:00 a.m. Today - PR Newswire - PRF
Developers #HackMS at the First Ever Hackathon for Multiple Sclerosis 8:32 a.m. Feb. 9, 2015 - PR Newswire - PRF
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancing New Drug Into Development to Treat a Neurodegenerative Disease 7:00 a.m. Feb. 5, 2015 - PR Newswire - PRF
RBCC and n3D Pursue New Partnership Opportunities After Highly Successful 3D Bioprinting Exhibit at Biotech Showcase 2015 5:00 a.m. Feb. 5, 2015 - BusinessWire - BZX
Notice Regarding Eisai's Options Relating To Biogen Idec's Investigational Anti-Alzheimer's Disease Treatments 11:21 p.m. Feb. 4, 2015 - JCN Newswire
Sangamo BioSciences Announces FDA Acceptance of IND to Initiate Clinical Trial of its Novel ZFP Therapeutic® for Beta-Thalassemia 7:00 a.m. Feb. 4, 2015 - PR Newswire - PRF
Critical Alerts For Zynga, Intercept Pharmaceuticals, Biogen, Nabors Industries and CyberArk Software Released By InvestorsObserver 9:31 a.m. Feb. 2, 2015 - PR Newswire - PRF
Regulus Earns Milestone Payment from Biogen Idec Related to the Identification of Potential microRNA Biomarkers in Multiple Sclerosis 8:00 a.m. Feb. 2, 2015 - PR Newswire - PRF
Biogen Idec, Fondazione Telethon and Ospedale San Raffaele Announce Global Collaboration to Develop Gene Therapies for Hemophilia 4:40 a.m. Jan. 29, 2015 - BusinessWire - BZX
Biotech Stocks Technical Report - Halozyme Therapeutics, Agenus, Biogen Idec, ACADIA Pharma, and Peregrine Pharma 8:40 a.m. Jan. 28, 2015 - PR Newswire - PRF
NFL Hall of Famer Earl Campbell And Son Tyler Campbell Pair Up With Biogen Idec To Celebrate The Inspiring Stories Of People With Relapsing Multiple Sclerosis 8:00 a.m. Jan. 28, 2015 - PR Newswire - PRF
CORRECTING AND REPLACING Biogen Idec to Report Fourth Quarter and Year End 2014 Financial Results on January 29, 2015 5:25 p.m. Jan. 26, 2015 - BusinessWire - BZX
Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain 1:27 p.m. Jan. 20, 2015 - PR Newswire - PRF
Isis Pharmaceuticals Earns $7M for Advancing ISIS-SMN Rx in Children With Spinal Muscular Atrophy 7:00 a.m. Jan. 14, 2015 - PR Newswire - PRF
3D Bioprinting Pioneers RBCC and n3D Biosciences Network With Top Biotechnology Investors This Week at Biotech Showcase 2015 in San Francisco 5:00 a.m. Jan. 13, 2015 - BusinessWire - BZX
Biogen Idec to Expand Neuropathic Pain Portfolio with the Acquisition of Convergence Pharmaceuticals 8:00 p.m. Jan. 11, 2015 - BusinessWire - BZX
Kite Pharma Expands Senior Management Team With Appointment of Claudine Prowse, Ph.D., as SVP, Corporate Communications and Investor Relations 8:01 a.m. Jan. 9, 2015 - GlobeNewswire
Incyte Board Appoints Two New Directors 8:00 a.m. Jan. 9, 2015 - BusinessWire - BZX
Biogen Idec and Columbia University Medical Center to Conduct Collaborative Genetics Research 8:00 a.m. Jan. 9, 2015 - BusinessWire - BZX
10 best, 10 worst S&P 500 stocks so far in 2015 12:01 p.m. Feb. 2, 2015 - Philip van Doorn
U.S. stocks routed in final hour, end month in the red 4:16 p.m. Jan. 30, 2015 - Sara Sjolin
Biogen, Intercept post double-digit gains 11:45 a.m. Jan. 30, 2015 - Russ Britt
Google, Amazon, Visa highlight gainers; Apple hits record 11:12 a.m. Jan. 30, 2015 - Sue Chang
Biogen Idec shares rally 7.1% 9:31 a.m. Jan. 30, 2015 - Sue Chang
Biogen's profit nearly doubles 5:37 p.m. Jan. 29, 2015 - MarketWatch.com
Updates, advisories and surprises 5:31 p.m. Jan. 29, 2015 - MarketWatch
Biogen shares jump after company reports earnings 4:30 p.m. Jan. 29, 2015 - Russ Britt
Bed Bath & Beyond shares sink as sales miss consensus 6:48 p.m. Jan. 8, 2015 - MarketWatch
Drug trials, upgrades boost health-care sector 11:57 a.m. Jan. 8, 2015 - Russ Britt
Biogen rises 6.2% after strong study results 7:56 a.m. Jan. 8, 2015 - MarketWatch
Biogen Idec shares up 5% in premarket trade 7:43 a.m. Jan. 8, 2015 - Ciara Linnane
Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Barbara Kollmeyer
Small caps rise within view of uncharted territory 10:26 a.m. Dec. 22, 2014 - Michael Ashbaugh
S&P 500 back for another crack at major support 10:14 a.m. Dec. 12, 2014 - Michael Ashbaugh
Biogen's Alzheimer's surprise 11:24 a.m. Dec. 9, 2014 - The Trading Deck
U.S. stocks post biggest gain in a month 5:06 p.m. Dec. 2, 2014 - Barbara Kollmeyer
Bob Evans earnings in spotlight after hours 3:41 p.m. Dec. 2, 2014 - Sue Chang
Biogen Alzheimer’s drug skips to Phase 3 testing 3:22 p.m. Dec. 2, 2014 - Russ Britt
CIO Network Members 11:01 p.m. Feb. 9, 2015 - The Wall Street Journal Interactive Edition
Will Sangamo (SGMO) Disappoint This Earnings Season? - Analyst Blog 1:10 p.m. Feb. 9, 2015 - Zacks.com
Healthcare stock screen of the month: Accelerating after-tax margins 12:21 p.m. Feb. 9, 2015 - Seeking Alpha
No Deceleration Here: 14 Stocks With Accelerating Profits 5:29 p.m. Feb. 6, 2015 - Investors Business Daily
PDL BioPharma: Beware The 8% Dividend 1:07 p.m. Feb. 6, 2015 - Seeking Alpha
Stock Market News for February 06, 2015 - Market News 10:10 a.m. Feb. 6, 2015 - Zacks.com
Sanofi Misses on Q4 Earnings, Maintains Diabetes Guidance - Analyst Blog 9:04 a.m. Feb. 6, 2015 - Zacks.com
Teva Beats on Q4 Earnings By a Penny, Maintains Outlook - Analyst Blog 9:01 a.m. Feb. 6, 2015 - Zacks.com
Gilead, Amgen Q4 Earnings And Weak Outlook Affect Biotech ETFs 7:17 a.m. Feb. 6, 2015 - Seeking Alpha
Gilead, Amgen Q4 Earnings & Weak Outlook Affect Biotech ETFs - ETF News And Commentary 2:01 a.m. Feb. 6, 2015 - Zacks.com
bluebird bio's Thalassemia Drug Gets Breakthrough Status - Analyst Blog 6:20 p.m. Feb. 5, 2015 - Zacks.com
Biogen Idec (BIIB) On Momo Momentum Watch Today 3:44 p.m. Feb. 5, 2015 - TheStreet.com
Perrigo Beats on Earnings, FY15 Guidance In Line - Analyst Blog 10:15 a.m. Feb. 5, 2015 - Zacks.com
Allergan Beats Earnings Yet Again on Strong Revenues - Analyst Blog 9:52 a.m. Feb. 5, 2015 - Zacks.com
10-K: BIOGEN IDEC INC. 4:41 p.m. Feb. 4, 2015 - Edgar Online - (EDG = 10Q, 10K)
3 Stocks Dragging In The Health Care Sector 12:13 p.m. Feb. 4, 2015 - TheStreet.com
Biotech Stock Roundup: Biogen Impresses with 4Q Results, Gilead & AbbVie HCV Drugs in Focus - Analyst Blog 11:47 a.m. Feb. 4, 2015 - Zacks.com
Merck (MRK) Beats on Q4 Earnings but Guidance Falls Short - Analyst Blog 11:21 a.m. Feb. 4, 2015 - Zacks.com
Jim Cramer: Don't Bail on Biotech or Chipotle Mexican Grill 10:58 a.m. Feb. 4, 2015 - TheStreet.com
Today's Market: Stocks On The Rise, Blowout Earnings And Dividend Increases 10:44 a.m. Feb. 4, 2015 - Seeking Alpha
Valuable Updates on Pharmaceutical Companies: New Research on Avalanche Biotechnologies, BioCryst, Biogen, Biota Pharmaceuticals, and Bio-Techne 8:30 a.m. Today - PR Newswire - PRF
Isis Pharmaceuticals Earns $5 Million Milestone Payment From Biogen Idec 7:00 a.m. Today - PR Newswire - PRF
Developers #HackMS at the First Ever Hackathon for Multiple Sclerosis 8:32 a.m. Feb. 9, 2015 - PR Newswire - PRF
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancing New Drug Into Development to Treat a Neurodegenerative Disease 7:00 a.m. Feb. 5, 2015 - PR Newswire - PRF
RBCC and n3D Pursue New Partnership Opportunities After Highly Successful 3D Bioprinting Exhibit at Biotech Showcase 2015 5:00 a.m. Feb. 5, 2015 - BusinessWire - BZX
Notice Regarding Eisai's Options Relating To Biogen Idec's Investigational Anti-Alzheimer's Disease Treatments 11:21 p.m. Feb. 4, 2015 - JCN Newswire
Sangamo BioSciences Announces FDA Acceptance of IND to Initiate Clinical Trial of its Novel ZFP Therapeutic® for Beta-Thalassemia 7:00 a.m. Feb. 4, 2015 - PR Newswire - PRF
Critical Alerts For Zynga, Intercept Pharmaceuticals, Biogen, Nabors Industries and CyberArk Software Released By InvestorsObserver 9:31 a.m. Feb. 2, 2015 - PR Newswire - PRF
Regulus Earns Milestone Payment from Biogen Idec Related to the Identification of Potential microRNA Biomarkers in Multiple Sclerosis 8:00 a.m. Feb. 2, 2015 - PR Newswire - PRF
Biogen Idec, Fondazione Telethon and Ospedale San Raffaele Announce Global Collaboration to Develop Gene Therapies for Hemophilia 4:40 a.m. Jan. 29, 2015 - BusinessWire - BZX
Biotech Stocks Technical Report - Halozyme Therapeutics, Agenus, Biogen Idec, ACADIA Pharma, and Peregrine Pharma 8:40 a.m. Jan. 28, 2015 - PR Newswire - PRF
NFL Hall of Famer Earl Campbell And Son Tyler Campbell Pair Up With Biogen Idec To Celebrate The Inspiring Stories Of People With Relapsing Multiple Sclerosis 8:00 a.m. Jan. 28, 2015 - PR Newswire - PRF
CORRECTING AND REPLACING Biogen Idec to Report Fourth Quarter and Year End 2014 Financial Results on January 29, 2015 5:25 p.m. Jan. 26, 2015 - BusinessWire - BZX
Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain 1:27 p.m. Jan. 20, 2015 - PR Newswire - PRF
Isis Pharmaceuticals Earns $7M for Advancing ISIS-SMN Rx in Children With Spinal Muscular Atrophy 7:00 a.m. Jan. 14, 2015 - PR Newswire - PRF
3D Bioprinting Pioneers RBCC and n3D Biosciences Network With Top Biotechnology Investors This Week at Biotech Showcase 2015 in San Francisco 5:00 a.m. Jan. 13, 2015 - BusinessWire - BZX
Biogen Idec to Expand Neuropathic Pain Portfolio with the Acquisition of Convergence Pharmaceuticals 8:00 p.m. Jan. 11, 2015 - BusinessWire - BZX
Kite Pharma Expands Senior Management Team With Appointment of Claudine Prowse, Ph.D., as SVP, Corporate Communications and Investor Relations 8:01 a.m. Jan. 9, 2015 - GlobeNewswire
Incyte Board Appoints Two New Directors 8:00 a.m. Jan. 9, 2015 - BusinessWire - BZX
Biogen Idec and Columbia University Medical Center to Conduct Collaborative Genetics Research 8:00 a.m. Jan. 9, 2015 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼